JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meding, J.
Right arrow Articles by Semmler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meding, J.
Right arrow Articles by Semmler, W.
Journal of Nuclear Medicine Vol. 43 No. 3 400-405
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Targeting of Endothelin Receptors for Molecular Imaging of Atherosclerosis in Rabbits

Jörg Meding, PhD1,2, Ludger M. Dinkelborg, PhD3, Manfred K. Grieshaber, PhD2 and Wolfhard Semmler, MD, PhD1,4

1 Institut für Diagnostikforschung GmbH, Berlin, Germany
2 Institut für Zoophysiologie Heinrich-Heine-Universität, Düsseldorf, Germany
3 Research Laboratories of Schering AG, Berlin, Germany
4 Biophysik und Medizinische Strahlenphysik E0200, Deutsches Krebsforschungszentrum, Heidelberg, Germany

We wanted to determine whether a previously described in vivo accumulation of a 99mTc-labeled endothelin derivative in atherosclerotic lesions is mediated by binding to endothelin receptors. Furthermore, the expression of endothelin receptors in atherosclerotic lesions of 2 different rabbit animal models for atherosclerosis was to be evaluated to determine whether endothelin receptors generally are a suitable target for atherosclerosis imaging. Methods: Normal vessels from untreated New Zealand White rabbits (NZW), balloon-denuded aortas from cholesterol-fed NZW, and atherosclerotic aortas from Watanabe Heritable Hyperlipidemic rabbits (WHHL) were used either as cross sections (cryosections) for receptor binding studies or for superfusion with a medium containing 125I-labeled endothelin-1 or the 99mTc-labeled endothelin derivative. Results: Cross sections of aortas from untreated NZW contained 45 ± 11.106 endothelin A receptors per square millimeter and 55 ± 11.106.endothelin B receptors per square millimeter, cross sections of balloon-denuded aortas from cholesterol-fed NZW contained 106 ± 16.106 endothelin A receptors per square millimeter and 27 ± 16.106 endothelin B receptors per square millimeter, and cross sections of atherosclerotic aortas from WHHL contained 40 ± 13.106 endothelin A receptors per square millimeter and 5 ± 13.106 endothelin B receptors per square millimeter. Balloon-denuded aortas from cholesterol-fed NZW (366 ± 132 amol.mm-2, P < 0.001) and atherosclerotic aortas from WHHL (338 ± 175 amol.mm-2, P < 0.002) accumulated significantly more of the 99mTc-labeled endothelin derivative than did vessels from control animals (137 ± 26 amol.mm-2). On the contrary, 125I-labeled endothelin-1–bound receptor mediated to superfused aortas from untreated NZW (12 ± 9 amol.mm-2) and to balloon-denuded aortas from cholesterol-fed NZW (19 ± 5 amol.mm-2) but not to aortas from WHHL. This lack of receptor-specific accumulation of 125I-endothelin-1 in atherosclerotic areas of WHHL aortas, and this receptor-specific accumulation in atherosclerotic balloon-denuded NZW aortas that does not significantly increase in comparison with normal aortas of untreated NZW, cause failure of endothelins to detect atherosclerotic lesions. Conclusion: Although the density and the ratio of endothelin receptor subtypes change because of the development of atherosclerotic lesions in rabbit aortas, endothelin receptor targeting for imaging of atherosclerosis is not suitable.

Key Words: endothelin derivative • endothelin receptor subtypes • atherosclerosis • molecular imaging • perfusion apparatus • receptor targeting







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.